Skip to content
Revolution Medicines

Senior Director, Corporate Affairs, Europe

Basel, Switzerland; Basel, SwitzerlandSwitzerland
Director+ · Corporate Communications
POSTED 18 NOVVERIFIED 40M AGO
Apply Ask
Role
0 days opentrue age
Closes in ~42d at the median (42d)
Posted 18 Nov · n=35
Pay
CHF 88k–CHF 90kno pay posted
Market p25–p75
CHF 88k–CHF 90k
Switzerland · n=83 · 365d to 15 Nov
CompanyRevolution Medicines →
337open roles
Opened · 30d
+49
Closed · 30d
−33
13d of snapshots · 30d window
Market
25,496open · Director+ Other
Opened · 7d
+2,67610% of open
All other
620,981open
All tracked boards · live 18 Nov · n=25,496

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity

The Senior Director, Corporate Affairs, Europe will lead the development and execution of oncology-focused Corporate Affairs & Communications strategies in Europe that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers. These strategies bring together media relations, corporate public affairs, product communications and corporate reputation management.

This is an intentionally broad remit, spanning a wide range of disciplines. We recognize that priorities will need to be set and will evolve over time. We are seeking a versatile leader who approaches this breadth as an opportunity and who understands that the scope of the role reflects the scale of our ambition as a growing business.

Reporting to the VP, Corporate Affairs, Europe, this role helps enable the success of local country organizations across the region. As part of a global team, this role also ensures that any activities in Europe align with global Corporate Affairs & Communications strategies. The success of this role also relies on working in close collaboration with functions such as Medical Affairs, Commercial, Patient Advocacy, and Value, Pricing and Market Access.

Key Responsibilities:

Media Relations

Develops and executes proactive media content and strategies around trial results, regulatory milestones, and major oncology congresses (ASCO, ESMO).

Works closely with the Global Corporate Affairs to coordinate contact with top-tier European and trade media, ensuring accurate representation of company positions and activities.

Monitors media coverage and sentiment and develops effective response strategies.

Ensures consistent messaging across earned, owned, and shared channels, and aligns spokesperson strategy and media plans with global priorities.

Corporate Reputation Management and Corporate Public Affairs

Leads the company’s reputation strategy across Europe, supporting country teams and ensuring a consistent company message and identity. Ensures this is co-developed by countries and the Global Corporate Affairs.

Assesses how the company is viewed by key audiences and identifies risks to its reputation.

Leads the regional response to crises and sensitive issues, protecting the company’s reputation and maintaining trust.

Works with the Global Corporate Communications team to strengthen the profile and credibility of company leaders among business, healthcare, and policy audiences, establishing them as authoritative voices on advances in cancer treatment.

Partners with the regional Value, Market Access and Pricing team to engage government bodies and other key institutions on issues that affect the company’s ability to operate and grow across Europe.

Product and Disease Area Communications

Works with regional commercial teams to lead oncology communications across Europe, from disease awareness through product launch and throughout the product’s lifecycle. This includes activity at major congresses (ASCO, ESMO) that explains clinical data to healthcare professionals and media audiences, as permitted by local regulatory requirements.

Creates disease awareness content for patients and caregivers and partners with Medical Affairs to explain clinical data in communications for healthcare professionals.

Source · Revolution MedicinesFirst seen 18 NovOriginal ↗